Chronic hypertension resident survival guide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

Hypertension Resident Survival Guide Microchapters
Overview
Classification
Causes
Diagnosis General Complete
Treatment Prehypertension Stage 1 Stage 2
Medications
Do's
Don'ts

Overview

Classification

Classification	Blood pressure (mmHg)
Normal	< 120/80
Prehypertension	120-139/80-89
Stage 1 hypertension	140-159/90-99
Stage 2 hypertension	≥ 160/110
Isolated systolic hypertension
Isolated diastolic hypertension

Causes

Life Threatening Causes

Common Causes

Diagnosis

Shown below is an algorithm summarizing the diagnosis of hypertension based on the seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and 2013 ESH/ESC guidelines for the management of arterial hypertension.

General Approach

Suspected hypertension BP > 140/90 mmHg

Blood pressure measurement Before taking the BP ❑ Sit patient quietly in a chair for 5 mins ❑ Avoid caffeine, exercise, smoking at least 30 mins ❑ Ensure appropriate cuff size ❑ Take 2 readings and find the average ❑ Take repeated measurements in patients with arrhythmia ❑ Measure BP at both arms at first visit to detect possible differences Click here for more information regarding blood pressure measurement

Office BP >140/90 mmHg on 2-3 visits

Does the patient have any evidence of target organ damage, DM, or CKD?

Yes

No

Proceed to hypertensive crisis resident survival guide

Perform home BP/out-of-office monitoring

Is the average home BP measurement <140/90?

Yes

Inconclusive

No

Perform 24-hour ABPM

Is the 24-hour ABPM ≤135/85?

White-coat hypertension confirmed

Yes

No

Hypertension confirmed

❑ Continue BP monitoring ❑ Follow-up appointment in ....

Classify the patient based on the BP reading

SBP 120-139 mmHg DBP - 80-89 mmHg

SBP 149-159 mmHg DBP 90-99 mmHg

SBP >160 mmHg DBP >110 mmHg

Prehypertension

Stage 1 hypertension Proceed to the complete diagnostic approach

Stage 2 hypertension Proceed to hypertensive crisis resident survival guide

Determine who to treat based on the following:

Complete Diagnostic Approach

Obtain a detailed history: History of present hypertension ❑ Time of first diagnosis ❑ Current and past BP measurements ❑ Current and past antihypertensive medications Identify secondary causes of hypertension: Family history ❑ Chronic kidney disease (suggestive of polycystic kidney disease) ❑ Premature CVD or HTN History of renal disease: ❑ Hematuria ❑ UTI ❑ Analgesic abuse (suggestive of renal parenchymal disease) ❑ Flank pain Medication/substance abuse ❑ Amphetamines ❑ Cocaine ❑ Cyclosporine ❑ Erythropoietin ❑ Liquorice ❑ NSAIDs ❑ Oral contraceptive pills ❑ Steroids History suggestive of pheochromocytoma ❑ Recurrent episodes of sweating, palpitation and hypertension History suggestive of hyperaldosteronism ❑ Muscle weakness and tetany History suggestive of thyroid disease History to assess risk factors ❑ Personal and family history of: ❑ HTN and CVD ❑ Dyslipidemia ❑ Diabetes mellitus ❑ Excessive sodium intake >2.4g per day ❑ Tobacco usage ❑ Obesity ❑ Alcoholism >1.5 drinks/day ❑ Metabolic syndrome ❑ Physical inactivity ❑ Sleep apnea History to assess presence of organ damage/complications ❑ CNS: ❑ Headache ❑ Vertigo ❑ Transient ischemic attack ❑ Stroke ❑ Eyes: ❑ Loss or blurring of vision ❑ Cardiovascular: ❑ History of MI or syncope ❑ Chest pain ❑ Shortness of breath ❑ Pedal edema ❑ Palpitation ❑ Arrhythmia ❑ Pedal edema ❑ Sexual function ❑ Kidneys: ❑ Polyuria ❑ Hematuria ❑ Proteinuria

Examine the patient: General examination: ❑ Calculate BMI ❑ Moon face, truncal obesity, striae (suggestive of cushing disease) ❑ Goitre, exophthalmus, pretibial myxedema (suggestive of graves disease) ❑ Dry skin (suggestive of hypothyroidism) Eyes ❑ Fundoscopy to diagnose retinopathy ❑ Hemorrhage ❑ Papilledema ❑ Cotton wool spots Neck ❑ Carotid bruits (suggestive of ) ❑ Thyroid gland enlargement (suggestive of hyperthyroidism) Cardiovascular examination ❑ Evidence of long-standing hypertension: ❑ Cardiomegaly ❑ Displaced apex beat (suggestive of enlarged left ventricle) Respiratory examination ❑ Crackles/crepitations/rales Abdominal examination ❑ Bruits over abdominal aorta (suggestive of aortic aneurysm) ❑ Bruits over renal artery (suggestive of renal artery stenosis) ❑ Extremity examination ❑ Absent or diminished femoral pulsation (suggestive of coarctation of aorta) ❑ Bruits over renal artery (suggestive of renal artery stenosis)Hepatomegaly ❑ Pedal edema (suggestive of congestive heart failure) ❑ Delayed return of deep tendon reflexes (suggestive of hypothyroidism) Neurological examination ❑ Findings suggestive of hypertensive encephalopathy ❑ Confusion ❑ Coma ❑ Altered mental status

Order tests: Routine ❑ 12-lead EKG (for evidence of LVH or old infarct) ❑ CBC ❑ Anemia (associated with chronic renal failure) ❑ Polycythemia (may be seen in pheochromocytoma) ❑ Urinalysis ❑ Proteinuria (suggestive of end organ damage) ❑ Serum potassium ❑ Hypokalemia (suggestive of hyperaldosteronism) ❑ Serum calcium ❑ Serum creatinine with estimated glomerular filtration rate (eGFR) ❑ Serum uric acid ❑ Fasting blood sugar ❑ Hyperglycemia (suggestive of diabetes mellitus) ❑ Fasting lipid profile Additional tests based on results of the routine tests above: ❑ Echocardiography (may reveal LVH or left ventricular mass) ❑ 24-hour urinary metanephrine and normetanephrine (elevated in pheochromocytoma) ❑ Plasma renin activity (PRA) (low renin suggests hyperaldosteronism) ❑ Plasma aldosterone (elevated in hyperaldosteronism) ❑ TSH (may be high or low in hypo- and hyperthyroidism, respectively) ❑ Serum parathyroid hormone (PTH) (To evaluate parathyroid disease) ❑ Dexamethasone suppression test ❑ Unchanged levels of cortisol to high dose dexamethasone suggests Cushing's syndrome ❑ 24-hour free urinary cortisol (elevated in Cushing's syndrome) ❑ Renal duplex ultrasound and magnetic resonance angiography (MRA) of renal arteries ❑ To evaluate renal artery stenosis ❑ Chest CT angiography (To evaluate aortic coarctation) ❑ Sleep study with O2 saturation (To evaluate sleep apnea)

Does this patient have an identifiable secondary etiology?

Yes

No

Primary hypertension

Secondary hypertension

Proceed to treatment

Treatment

Shown below is an algorithm summarizing the treatment of

Prehypertension

Stage 1 Hypertension

Determine who to treat: ❑ BP ≥ 150/90 mmHg in patients ≥ 60 years ❑ BP ≥ 140/90 mmHg in patients < 60 years ❑ BP ≥ 140/90 mmHg in patients ≥ 18 years with CKD or DM

Review BP goals: General population ❑ BP < 150/90 mmHg in patients ≥ 60 years ❑ BP < 140/90 mmHg in patients < 60 years Patients with DM or CKD ❑ BP < 140/90 mmHg in patients

Initiate lifestyle modification: ❑ Weight reduction ❑ Maintain a waist circumference of <40 inches (102cm) for men <35 inches (88cm) for women BMI of ≤25 kg/m2 ❑ Adopt healthy diet ❑ DASH diet (rich in fruits, vegetables, whole grains, low sodium, low-fat proteins) ❑ Dietary sodium intake of ≤ 100 mmol/day (2.4g Na or 6g NaCl) ❑ Limit alcohol consumption ❑ ≤ 2 drinks/day for men (24oz beer or 10oz wine or 3oz 40% whisky ❑ ≤ 1 drink/day for women ❑ Regular aerobic physical activity (brisk walking, jogging, cycling, swimming) for at least 30 mins per day ❑ Patient education

Does the patient have DM or CKD?

Yes

No

CKD ± DM

DM only

Consider the race of the patient

Black population

Non-black population

Initiate: ❑ ACE inhibitors alone, OR ❑ ARBs alone, OR ❑ ACEI or ARBs in combination with other drug class e.g., Avoid the combine use of ACEIs and ARBs in a patient

Initiate: ❑ Thiazide-type diuretic alone, OR ❑ CCB alone, OR ❑ Combination of the two classes

Initiate: ❑ Thiazide-type diuretic alone, OR ❑ ACEI alone, OR ❑ ARBs alone, OR ❑ CCB alone, OR ❑ Combination of all the classes Avoid the use of ACEIs and ARBs in combination

Has the target BP been reached?

Yes

No

Consider the following: ❑ ❑ ❑ ❑ ❑

Monitoring and follow-up: ❑ ❑ ❑ ❑ ❑

Medications

Drug Class	Drug	Initial daily dose, target dose (mg)
Thiazide diuretics	Chlorthalidone	12.5, 12.5-25
	Hydrochlorothiazide	12.5-25, 25-100
	Bendroflumethiazide	5, 10
	Indapamide	1.25, 1.25-2.5
ACE inhibitors	Enalapril	5, 20
	Lisinopril	10, 40
	Captopril	50, 150-200
ARBs	Candesartan	4, 12-32
	Losartan	50, 100
	Valsartan	40-80, 160-320
	Eprosartan	400, 600-800
	Irbesartan	75, 300
Beta blockers	Atenolol	25-50, 100
	Metoprolol succinate	50, 100-200
Calcium channel blockers	Amlodipine	2.5, 10
	Diltiazem extended release	120-180, 360
	Nitrendipine	10, 20

Do's

Don'ts

References

Template:WikiDoc Sources